V W Stieber

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi Glossopharyngeal neuralgia treated with gamma knife surgery: treatment outcome and failure analysis. Case report
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    J Neurosurg 102:155-7. 2005
  2. ncbi Low-grade gliomas
    V W Stieber
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Curr Treat Options Oncol 2:495-506. 2001
  3. ncbi The role of radiosurgery in the management of malignant brain tumors
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Curr Treat Options Oncol 6:501-8. 2005
  4. ncbi Determination of a clinical value for the repair half-time (T1/2) of the trigeminal nerve based on outcome data from gamma knife radiosurgery for facial pain
    Volker Stieber
    Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Radiat Res 168:143-8. 2007
  5. ncbi Gentlemen (and ladies), choose your weapons: Gamma knife vs. linear accelerator radiosurgery
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Technol Cancer Res Treat 2:79-86. 2003
  6. ncbi Advances in radiation therapy for brain tumors
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Neurol Clin 25:1005-33, ix. 2007
  7. ncbi Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy
    Paul K Kim
    Department of Neurosurgery, Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157, USA
    J Neurosurg 105:75-8. 2006
  8. ncbi Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy
    William T Kearns
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Winston Salem, NC, USA
    J Appl Clin Med Phys 9:2763. 2008
  9. ncbi Reducing set-up uncertainty in the Elekta Stereotactic Body Frame using Stealthstation software
    William H Hinson
    Department of Radiation Oncology, Wake Forest University, School of Medicine, Winston Salem, North Carolina 27157, USA
    Technol Cancer Res Treat 6:181-6. 2007
  10. ncbi Optically guided linac radiosurgery with a Leksell head frame as an adjunct to Gamma Knife treatment
    Kenneth E Ekstrand
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Technol Cancer Res Treat 6:123-6. 2007

Detail Information

Publications21

  1. ncbi Glossopharyngeal neuralgia treated with gamma knife surgery: treatment outcome and failure analysis. Case report
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    J Neurosurg 102:155-7. 2005
    ..The authors present the first report of GKS-treated GPN in a patient who presented with severe, poorly controlled GPN and who refused MVD...
  2. ncbi Low-grade gliomas
    V W Stieber
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Curr Treat Options Oncol 2:495-506. 2001
    ..Radiosurgery and/or experimental chemotherapy may provide some measure of local control in the recurrent disease setting...
  3. ncbi The role of radiosurgery in the management of malignant brain tumors
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Curr Treat Options Oncol 6:501-8. 2005
    ..In selected patients with brain metastases, it is also rational to withhold WBRT in favor of radiosurgery alone, with WBRT reserved for salvage without a decrease in median survival time...
  4. ncbi Determination of a clinical value for the repair half-time (T1/2) of the trigeminal nerve based on outcome data from gamma knife radiosurgery for facial pain
    Volker Stieber
    Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Radiat Res 168:143-8. 2007
    ..28-1.77 h for T(1/2). The biological model appeared to accurately predict that, given the doses and treatment times used in general clinical practice, there would be no significant difference in clinical outcome...
  5. ncbi Gentlemen (and ladies), choose your weapons: Gamma knife vs. linear accelerator radiosurgery
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Technol Cancer Res Treat 2:79-86. 2003
    ....
  6. ncbi Advances in radiation therapy for brain tumors
    Volker W Stieber
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1030, USA
    Neurol Clin 25:1005-33, ix. 2007
    ..In the dose range used when treating these tumors, the probability of causing serious late toxicity is relatively low and secondary malignancies are rare...
  7. ncbi Gamma Knife surgery targeting the resection cavity of brain metastasis that has progressed after whole-brain radiotherapy
    Paul K Kim
    Department of Neurosurgery, Wake Forest University Baptist Medical Center, Winston Salem, North Carolina 27157, USA
    J Neurosurg 105:75-8. 2006
    ..The authors describe their experience in using Gamma Knife surgery (GKS) to target the resection cavity in patients whose tumors had progressed after WBRT...
  8. ncbi Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy
    William T Kearns
    Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Winston Salem, NC, USA
    J Appl Clin Med Phys 9:2763. 2008
    ..The PET/CT-based SBRT simulations are safe and important for treatment planning that optimizes biologic dose distribution with highly accurate and reproducible target definition...
  9. ncbi Reducing set-up uncertainty in the Elekta Stereotactic Body Frame using Stealthstation software
    William H Hinson
    Department of Radiation Oncology, Wake Forest University, School of Medicine, Winston Salem, North Carolina 27157, USA
    Technol Cancer Res Treat 6:181-6. 2007
    ..6 mm accuracy of phantom-to-SBF alignment was measured. The results on four actual patients showed setup errors of 1.5 mm or less. Using the Stealth Station process, rapid confirmation of alignment on the treatment table is possible...
  10. ncbi Optically guided linac radiosurgery with a Leksell head frame as an adjunct to Gamma Knife treatment
    Kenneth E Ekstrand
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Technol Cancer Res Treat 6:123-6. 2007
    ..We have measured the accuracy of the optical tracking system using a phantom attached to a Leksell frame and have determined that the system can target a linear accelerator radiosurgery beam to an accuracy of within 1 millimeter...
  11. ncbi Interim analysis of a prospective phase I/II trial of SBRT for liver metastases
    Brian D Kavanagh
    Department of Radiation Oncology, University of Colorado, Aurora, Colorado 80045, USA
    Acta Oncol 45:848-55. 2006
    ..This interim analysis indicates that a very high rate of durable in-field tumor control can be safely achieved with SBRT to 1-3 liver lesions as administered in this protocol, to a prescription dose of 60 Gy in 3 fractions...
  12. ncbi Oligodendroglioma
    Thomas L Ellis
    Department of Neurosurgery, Wake Forest University School of Medicine, Winston Salem, NC 27105, USA
    Curr Treat Options Oncol 4:479-90. 2003
    ..In addition, selected patients should receive chemotherapy. Clinical trials remain critical to advancing our understanding of these tumors and improving our ability to cure these patients...
  13. ncbi Meningioma: current treatment options and future directions
    Kevin P McMullen
    Comprehensive Cancer Center of Wake Forest University, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Curr Treat Options Oncol 5:499-509. 2004
    ..The role of systemic therapy is not yet defined, but multiple agents are being investigated in early phase trials for patients with recurrent or progressive disease after standard therapy has failed...
  14. ncbi Current controversies in the radiotherapeutic management of adult low-grade glioma
    Edward G Shaw
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Semin Oncol 31:653-8. 2004
    ..Further prospective clinical trials are needed to define the optimal management strategy for adults with supratentorial LGG. The schemata from recently completed and ongoing LGG studies will be presented...
  15. ncbi Lessons learned from randomised clinical trials in adult low grade glioma
    Michael A Papagikos
    Department of Radiation Oncology, Comprehensive Cancer Center, Wake Forest University Baptist Medical Center, Winston Salem, NC 27157, USA
    Lancet Oncol 6:240-4. 2005
    ..The goal is to show that the lessons learned are not necessarily literal or dogmatic but can be much more allegorical in nature...
  16. ncbi Does dose rate affect efficacy? The outcomes of 256 gamma knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt
    Christopher J Balamucki
    Department of Neurosurgery, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    J Neurosurg 105:730-5. 2006
    ..26 years. The authors examined whether the decrease in dose rate over 4.6 years between Co source replacements affected the control rates of facial pain in patients undergoing GKS...
  17. ncbi The use of a Leksell-BRW adapter for linac radiosurgery as an adjunct to Gamma Knife treatment
    Kenneth E Ekstrand
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC, USA
    Phys Med Biol 48:4105-10. 2003
    ..We have found that with this device objects within a head phantom can be targeted by the linear accelerator within an accuracy of approximately 1 mm...
  18. doi Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
    Kyle E Rusthoven
    University of Colorado Denver, Department of Radiation Oncology, Pathology, and Medical Oncology, Aurora, CO 80045, USA
    J Clin Oncol 27:1572-8. 2009
    ..To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases...
  19. doi Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors
    Stacy Wentworth
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC, USA
    Int J Radiat Oncol Biol Phys 73:208-13. 2009
    ..Patients with neurofibromatosis (NF) develop tumors of the central nervous system (CNS). Radiation therapy (RT) is used to treat these lesions. To better define the efficacy of RT in these patients, we reviewed our 20-year experience...
  20. doi Radiation therapy for visual pathway tumors
    Volker W Stieber
    Department of Radiation Oncology, Derrick L Davis Forsyth Regional Cancer Center, 3333 Silas Creek Parkway, Winston Salem, NC 27103, USA
    J Neuroophthalmol 28:222-30. 2008
    ..The risk of complications from radiation treatment is dependent on the organ at risk, the cumulative dose it receives, and the dose delivered per fraction...
  21. ncbi Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases
    Lisa R Rogers
    Department of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, Michigan 48109 0316, USA
    J Neurosurg 105:375-84. 2006
    ..The primary end point of the study was local tumor control. The secondary end points included patient survival, distant brain recurrence, quality of life, and treatment toxicity...